Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
28.6%
% of PBE's 28 holdings also in GNOM
19.0%
% of GNOM's 42 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PBE |
Weight in GNOM |
Overlap | |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 5.0% | 6.2% | 5.0% | |
ILLUMINA INC | 5.1% | 3.5% | 3.5% | |
BIO-TECHNE CORPORATION | 3.1% | 4.0% | 3.1% | |
VERACYTE INC | 3.0% | 4.1% | 3.0% | |
NATERA INC | 3.0% | 4.5% | 3.0% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to GNOM
AMGEN INC | 5.3% | |
UNITED THERAPEUTICS CORP | 5.2% | |
BIOGEN IDEC INC | 5.0% | |
REGENERON PHARMACEUTICALS | 4.9% | |
NEUROCRINE BIOSCIENCES INC | 4.0% | |
XENCOR INC | 3.4% | |
NOVAVAX INC | 3.2% | |
PROTAGONIST THERAPEUTICS, INC. | 3.1% | |
TG THERAPEUTICS INC | 3.0% | |
ACADIA PHARMACEUTICALS INC | 2.9% |
PBE Underweight Relative to GNOM
ENI SPA-SPONSORED ADR | -7.9% | |
AVIDITY BIOSCIENCES INC | -5.1% | |
ULTRAGENYX PHARMACEUTICAL IN | -4.3% | |
BIONTECH SE SPONSORED ADR | -4.1% | |
QIAGEN NV | -3.5% | |
LEGEND BIOTECH CORPORATION SPONSORED | -3.5% | |
SAREPTA THERAPEUTICS INC | -3.3% | |
AGILENT TECHNOLOGIES INC | -3.3% | |
INTELLIA THERAPEUTICS, INC. | -3.3% | |
ARROWHEAD PHARMACEUTICALS, INC. | -2.9% |